{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/how-fortrea-brought-agile-partnership-approach-delivering-new-oncology-model#webpage",
"url": "https://www.fortrea.com/insights/how-fortrea-brought-agile-partnership-approach-delivering-new-oncology-model",
"name": "How Fortrea brought an agile partnership approach to delivering a new oncology model",
"description": "This Fortrea case study explores how an agile partnership model supported oncology clinical development across complex hematologic malignancy clinical trials and early phase oncology programs. Delivering phase I-IV oncology clinical trials requires flexible operational strategies, efficient clinical trial project management, and the ability to adapt quickly to evolving study demands. The case study highlights how adaptive clinical trial delivery, integrated sponsor collaboration, and streamlined execution supported the advancement of cancer treatment clinical trials in hematological malignancies. By implementing an agile partnership approach, the program improved coordination across oncology clinical trial phases, enhanced operational efficiency, and supported timely study delivery in a rapidly changing development environment. This case study demonstrates how flexible oncology clinical development models can strengthen execution, improve collaboration, and support successful outcomes across complex oncology clinical trials."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "How Fortrea brought an agile partnership approach to delivering a new oncology model",
"item": "https://www.fortrea.com/insights/how-fortrea-brought-agile-partnership-approach-delivering-new-oncology-model"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/how-fortrea-brought-agile-partnership-approach-delivering-new-oncology-model#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/how-fortrea-brought-agile-partnership-approach-delivering-new-oncology-model#webpage"
},
"headline": "How Fortrea brought an agile partnership approach to delivering a new oncology model",
"description": "This Fortrea case study explores how an agile partnership model supported oncology clinical development across complex hematologic malignancy clinical trials and early phase oncology programs. Delivering phase I-IV oncology clinical trials requires flexible operational strategies, efficient clinical trial project management, and the ability to adapt quickly to evolving study demands. The case study highlights how adaptive clinical trial delivery, integrated sponsor collaboration, and streamlined execution supported the advancement of cancer treatment clinical trials in hematological malignancies. By implementing an agile partnership approach, the program improved coordination across oncology clinical trial phases, enhanced operational efficiency, and supported timely study delivery in a rapidly changing development environment. This case study demonstrates how flexible oncology clinical development models can strengthen execution, improve collaboration, and support successful outcomes across complex oncology clinical trials.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-03/agile-partnership-approach-to-delivering-new-oncology-model.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-20",
"dateModified": "2025-03-20",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-03/agile-partnership-approach-to-delivering-new-oncology-model.pdf`",
"encodingFormat": "application/pdf"
}
}
]
}